Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

Borba, Mayla Gabriela Silva, Val, Fernando Fonseca Almeida, Sampaio, Vanderson Souza, Alexandre, Marcia Almeida Araújo, Melo, Gisely Cardoso, Brito, Marcelo, Mourão, Maria Paula Gomes, Brito-Sousa, José Diego +21 more·2020·JAMA Network Open
DOI 10.1001/jamanetworkopen.2020.8857

Cited by (1,000)

Items 801–900 of 1,000

  1. Chloroquine and hydroxychloroquine – safety profile of potential COVID-19 drugs from the rheumatologist’s perspective
    Dominik Majewski, Katarzyna Anna Majewska, Monika Naskręcka, Bogna Grygiel‐Górniak · 2020 · Annals of Agricultural and Environmental Medicine
  2. Management and Prevention of Cerebrovascular Accidents in SARS-CoV-2–Positive Patients Recovering from COVID-19: a Case Report and Review of Literature
    Masoud Yeganegi, Pooia Fattahi · 2021 · SN Comprehensive Clinical Medicine
  3. Uso de aminoquinolinas (Cloroquina e Hidroxicloroquina) no tratamento da COVID-19: uma revisão sistemática
    Luan Victor Almeida Lima, Filipe Saboya Santos, Nataly Abreu Alves, Sabrina Sales Alves, Iury Magalhães Dutra de Melo, Tereza de Jesus Pinheiro Gomes Bandeira · 2021 · Research Society and Development
  4. Chloroquine: An Old to be Repurposed Drug For COVID-19 Infection (Risk and Benefit)
    Oki Nugraha Putra, Ana Khusnul Faizah, Nani Wijayanti Dyah Nurrahman, Hardiyono Hardiyono · 2020 · Pharmaceutical Sciences and Research
  5. Early Insights into COVID-19 in Persons Living with HIV and Cardiovascular Manifestations
    Jelani Kayode Grant, Louis Thomas Vincent, Bertrand Ebner, Barry E. Hurwitz, Maria Luisa Alcaide, Claudia A. Martinez · 2020 · Journal of AIDS and HIV Treatment
  6. Current Treatments of Coronavirus Disease 2019 in Elderly
    Jaeyoung Park · 2020 · 대한임상노인의학회지
  7. A review on the clinical trials of repurposing therapeutic drugs, mechanisms and preventive measures against SARS-CoV-2
    Eleazer U. Ikonne, Victor Okezie Ikpeazu, Ositadinma Chinyere Ugbogu, Okezie Emmanuel, Ikechukwu P. Nwakuche, Emeka Iweala, Eziuche Amadike Ugbogu · 2021 · Drug metabolism and drug interactions
  8. Coronavirus Disease 2019: An Overview of the Complications and Management
    Huimin Shao, Hany Sadek Ayoub Ghaly, Pegah Varamini · 2021 · INNOSC Theranostics and Pharmacological Sciences
  9. Antimalarial and Antiviral Drugs: A Review of Trials and Effectivenessin Treating COVID-19
    Chandra Adwani · 2021 · Bioscience Biotechnology Research Communications
  10. COVID-19 versus Seasonal Influenza: Comparison of Profiles of Older Adults Hospitalized in a Short-Term Geriatric Ward in France
    Lidvine Godaert, Agnès Cebille, Emeline Proye, Moustapha Dramé · 2021 · American Journal of Tropical Medicine and Hygiene
  11. Cardiometabolic Morbidity and Other Prognostic Factors for Mortality in Adult Hospitalized COVID-19 Patients in North Jakarta, Indonesia
    Arvin Pramudita, Siti Rosidah, Novi Yudia, Jeffri Simatupang, Wulan Pingkan Sigit, Rita Novariani, Priscilia Myriarda, Bambang Budi Siswanto · 2022 · Global Heart
  12. Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022)
    Horst Olschewski, Ernst Eber, Brigitte Bucher, Klaus Hackner, Sabin Handzhiev, Konrad Höetzenecker, Marco Idzko, Walter Klepetko, Gábor Kovács, Bernd Lamprecht et al. · 2022 · Wiener klinische Wochenschrift
  13. Discutindo fake news sobre química durante a pandemia da COVID-19
    Felipe Vitório Ribeiro, Ana Paula de Oliveira Amorim, Carlos da Silva Lopes · 2022 · Revista Thema
  14. Hypertension related toxicity of chloroquine explains its failure against COVID-19: Based on rat model
    Junqi Wang, Xian Jing, Lizhong Hua, Yuling Zheng, Shiheng Hu, Jing Xiao, Dawei Guo, Wenda Wu, Hui Ji, Lin Peng et al. · 2022 · Frontiers in Pharmacology
  15. The Penn Medicine COVID-19 Therapeutics Committee—Reflections on a Model for Rapid Evidence Review and Dynamic Practice Recommendations During a Public Health Emergency
    George L. Anesi, Kathleen O. Degnan, Lauren S Dutcher, Stephen Saw, Christina Maguire, Amanda Binkley, Sonal Patel, Vasilios Athans, Todd D. Barton, Shawn Binkley et al. · 2023 · Open Forum Infectious Diseases
  16. Chloroquine and Hydroxychloroquine in Treatment of COVID-19 Disease
    Fatma Yıldırım · 2020 · Journal of Critical and Intensive Care
  17. Status of chloroquine and hydroxychloroquine in COVID-19 infection
    Savita Ramesh Shahani, Lokesh Shahani · 2020 · International Journal of Basic & Clinical Pharmacology
  18. Systemische Immunsuppression in Zeiten von COVID‐19: Müssen wir umdenken?
    Stephan Grabbe, Stefan Beissert, Alexander Enk · 2020 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
  19. Perspectives on COVID-19 therapies: conflicts and consensus
    Kaline Romeiro, Régida Cléa da Silva Batista, Luciana Ferraz Gominho, Caio Vinícius Batista de Arruda, Antônio Carlos Moura, Diana Santana de Albuquerque, Marleny Elizabeth Márquez de Martínez Gerbi, Marcely Cassimiro · 2020 · Research Society and Development
  20. Specific Treatment of COVID-19
    Ayşe Alga Batırel · 2020 · Southern Clinics of Istanbul Eurasia
  21. JAMA Network Open and COVID-19
    Frederick P. Rivara, Stephan D. Fihn, Eli N. Perencevich · 2020 · JAMA
  22. COVID-19 pandemic: Case studies and perspectives
    Michael Liu · 2020 · Side effects of drugs annual
  23. Structure-guided discovery approach identifies potential lead compounds targeting Mpro of SARS-CoV-2
    Mohcine Elmessaoudi-Idrissi, Kyoko Tsukiyama–Kohara, Jalal Nourlil, Anass Kettani, Marc Peter Windisch, Michinori Kohara, Yashpal Singh Malik, Kuldeep Dhama, Soumaya Benjelloun, Sayeh Ezzikouri · 2020 · VirusDisease
  24. Pharmacodynamics of Remdesivir: How to Improve for COVID-19 Treatment
    Ashok K. Chakraborty, Anil R. Diwan · 2020 · Journal of Biomedical Research & Environmental Sciences
  25. COVID-19 and the Challenges of Chemotherapy: The Failure Case of Hydroxychloroquine in the Clinical Treatment of SARS-CoV-2 Infection
    Pollyanna Stephanie Gomes, Patrícia de Almeida Machado, Andre M.O. Gomes, Andréa Cheble de Oliveira, Jerson Lima Silva, Herbert Leonel de Matos Guedes · 2021 · Coronaviruses
  26. Innovative diagnostic approach and investigation trends in COVID19-A systematic review
    N Gururaj, J Beryl Rachel, T. V. Smitha, TDivyna Daniel, BS Harishini, AdlinS Rosaian · 2020 · Journal of Oral and Maxillofacial Pathology
  27. Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin
    Abraham Edgar Gracia‐Ramos, Antonio Cortés‐Ortíz · 2021 · Oxford Medical Case Reports
  28. JAMA Network Open—The Year in Review, 2020
    Frederick P. Rivara, Stephan D. Fihn · 2021 · JAMA Network Open
  29. Interactions between Cytokines and Drugs in COVID-19 Potential Interactions between Increased Cytokines in COVID-19 and Drugs used to Treat COVID-19
    Tülün Öztürk, Tuğba Çavuşoğlu, Canet İncir, Yeşim Tunçok · 2021 · Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
  30. Hydroxychloroquine for Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Challenges to Trial Conduct During the Global Pandemic
    Jason D. Goldman · 2020 · Clinical Infectious Diseases
  31. Cloroquina e hidroxicloroquina no Brasil: um caso de ineficácia na gestão da saúde pública
    Diego de Oliveira Souza · 2021 · Revista de Salud Pública
  32. Perfil de prescrições de medicamentos para o tratamento da Covid-19 no Hospital Geral da Unimed, Belém, Pará, Amazônia
    Ivan Pereira da Silva, Maycon Ruan Lima de Araújo, José Ronaldo Teixeira de Sousa, Antônio dos Santos Silva, Luana Melo Diogo de Queiroz, Márcia Maria Barros dos Passos, Orenzio Soler · 2021 · Research Society and Development
  33. Efficacy and Safety of Hydroxychloroquine and Chloroquine for COVID-19: A systematic review
    Sonal Singh, Thomas J Moore · 2020 · medRxiv
  34. A Systematic Review and Network Meta-Analysis for COVID-19 Treatments
    Chenyang Zhang, Huaqing Jin, Yifeng Wen, Guosheng Yin · 2020 · medRxiv
  35. Recapitulation of Antimalarial Drugs use in the Prevention and Treatment of Novel Coronavirus Disease
    Maham Zahid, Kinza Waqar, Nafisa Tahir · 2020 · Life and Science
  36. Hydroxychloroquine/Chloroquine in COVID-19 With Focus on Hospitalized Patients – A Systematic Review
    Daniel Freilich, Jennifer M. Victory, Anne Gadomski · 2022 · medRxiv
  37. Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications
    AISDL · 2021
  38. Saúde pública, justiça e cloroquina: aspectos farmacoepidemiológicos e reflexões bioéticas da pandemia da COVID-19 no Brasil
    Eric Bitencourt de Santana, Luanna Gabriela Völz · 2020 · Voluntas Revista Internacional de Filosofia
  39. Journey of Chloroquine/ Hydroxychloroquine in the management of COVID-19
    Kavita Sekhri, Sangeeta Bhanwra, Ruchika Nandha, Suruchi Aditya, Deepak Kumar Bhasin · 2022 · Research Journal of Pharmacology and Pharmacodynamics
  40. Adverse drug reactions associated with COVID-19 management
    Vivek P. Chavda, Payal Dodiya, Vasso Apostolopoulos · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
  41. The EFFECTS OF ANTIVIRAL THERAPEUTIC DRUGS FOR SARS-COV-2 ON TREATMENT OUTCOMES AND CLINICAL PARAMETERS
    Abdul Bari, Atiqullah Sarwari, Mohammad Hassan, Abdul Wahid, Parwiz Niazi, Abdul Qadeer Baseer, Sayedwali Sediqi, Uzair Mohammad Kakar · 2024 · Eurasian Journal of Ecology
  42. Effect of the Coronavirus Disease 2019 Pandemic on the Sexual Functions of Healthcare Providers
    Hesham N. Khaled, Mohamed Nassef, Ayman Abd El-Fattah El-Haddad · 2025 · Sexuality Research and Social Policy
  43. Atuação de enfermeiras(os) obstetras durante o trabalho de parto/parto: Relato de experiência
    Maí­ra Maria Leite de Freitas, Juliana da Silva Magalhães, Cláudia Patrícia da Silva Ribeiro Menezes, Leticia Machado de Sousa, Claudiana dos Santos Silva, #REF! #REF!, Antônio Gean Fernandes Lopes, Maria Madalena da Silva Araújo · 2020 · Editora Poisson eBooks
  44. ‘Convalescent Plasma’- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review
    Sumel Ashique, Tahamina Khatun, Garima Sahu, Aakash Upadhyay, Archana Adhana, Shubneesh Kumar, Navjot Kaur Sandhu, Nitish Kumar · 2022 · Infectious Disorders - Drug Targets
  45. The Effects of Coronavirus on Human Health and Their Influence on Other Aspects of Life: A Scoping Review
    Said M.R. Kewedar, Khaleel Adel Ahmed Abulamoun · 2022 · Biosciences Biotechnology Research Asia
  46. Small molecules targeting endolysosomal acidification and signaling in sepsis and severe SARS-CoV-2 infection/COVID-19
    Markus F. Blaess, Oliver Sommerfeld, René Csük, Hans‐Peter Deigner · 2022 · Exploration of Immunology
  47. Hydroxychloroquine and COVID-19 story: is the low-dose treatment the missing link? A comprehensive review and meta-analysis
    Idir Ramdani, Belaïd Bouazza · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
  48. Arbidol increases the survival rate by mitigating inflammation in suckling mice infected with human coronavirus OC43 virus
    Hongxia Zhou, Peifang Xie, Minshan Qiu, Shuwei Dong, Xueshan Xia, Zifeng Yang, Yaoqin Yuan, Lihan Shen · 2023 · Journal of Medical Virology
  49. Drug repurposing for the treatment of patients infected with SARS-CoV-2
    Guilherme Martins, Thiago S. Castro, Daví A. C. Ferreira · 2024 · Network Modeling Analysis in Health Informatics and Bioinformatics
  50. An Analytic Look at the Last Pandemic’s Spread and Its Control by Decision-Makers
    THOMAS NOGUEIRA VILCHES, Felipe Alves Rubio, Gabriel Berg de Almeida, Cláudia Pio Ferreira · 2024 · Modeling and simulation in science, engineering & technology
  51. Clinical Characteristics and Outcomes of First 100 Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-Cov-2) Patients: A Single Center Experience
    Kashif Naeem, Vinod Choondal, Mahmoud Hamouri, Ahmed Abbas, Sreevidya Machingal, Farzeela Fahad, Kusay Almusa, Mona Osman, Afaf Ashoor, Mahdi Sial et al. · 2020 · European Journal of Medical and Health Sciences
  52. Tratamiento De COVID-19. Mitos Y Realidades Bajo La Perspectiva De La Investigación Clínica [Treatment Of COVID-19. Myths And Realities Under The Perspective Of Clinical Research]
    Osvaldo Reyes · 2020 · Revista de la Federación Centroamericana de Obstetricia y Ginecología
  53. COVID-19: making the right diagnosis
    Gordon D. Schiff, Maria Mirica · 2020 · Diagnosis
  54. Medicinal products used for the treatment and prophylaxis of COVID-19
    A. Vaitkevičius · 2020 · Neurologijos seminarai
  55. Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned
    Sherif Sultan, Yogesh Acharya · 2020 · Vascular
  56. EVENTOS ADVERSOS A MEDICAMENTOS NO TRATAMENTO DA COVID-19 NO CEARÁ: ADVERSE EVENTS TO MEDICINES IN THE TREATMENT OF COVID-19 IN CEARÁ
    Fernanda França Cabral, Maíra Barroso Pereira, Karla Deisy Morais Borges, Ana Cláudia de Brito Passos, Eudiana Vale Francelino, Mirian Parente Monteiro, Paulo Sérgio Dourado Arrais · 2020 · Cadernos ESP - Revista Científica da Escola de Saúde Pública do Ceará
  57. Chloroquine and Hydroxychloroquine: Are they really wonder drugs for COVID 19?
    MD. Abu Bashar, Nazia Begam · 2020 · The Journal of Community Health Management
  58. Do in vitro ao in vivo: a eficácia da cloroquina no tratamento da COVID-19
    Filipe Mosca Guerra · 2020 · Journal of Evidence-Based Healthcare
  59. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
    Mohamed Farouk Allam, Fady Andraous · 2020 · Central European Journal of Public Health
  60. Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths
    Shivraj Padiyar, Debashish Danda · 2020 · European Journal of Rheumatology
  61. Decoding the silent walk of COVID-19: Halting its spread using old bullets
    Mukesh Kumar, Jitender Madan, Rupinder Kaur Sodhi, Shashi Bala Singh, Anju Katyal · 2020 · Biomedicine & Pharmacotherapy
  62. A Summary of Coronavirus Disease 2019: What We Should Know?
    Ysrafil Ysrafil, Indwiani Astuti, Rosdiana Mus, Noviyanty Indjar Gama, Dwi Rahmaisyah, Riskah Nur’amalia · 2020 · Pharmaceutical Sciences
  63. Mães adolescentes: Direito à escolarização durante hospitalização do filho na UTI neonatal
    Danúbia Ramos dos Santos Mozeléski, Luciane Costa Simões da Silva, Regina Maria Fialkoski Basso · 2020 · Editora Poisson eBooks
  64. A eficácia dos testes clínicos de campo na avaliação da capacidade funcional dos pacientes com DPOC: Uma revisão de literatura
    Leidyane de Almeida Gonçalves, Daniele Maria dos Santos, Alexa Alves de Moraes, Bárbara Renatha Afonso Ferreira de Barros leite · 2020 · Editora Poisson eBooks
  65. Coronavirus 2019 pandemic and renal diseases: a review of the literature
    Osama Ashry Ahmed Gheith, Ayman Maher, Ahmed Abbas, Mohamed Emam, Medhat A Halim, Soheir M Zain Eldein, Tarek S H Mahmoud, Nashwa Farouk Othman, Prasad M. Nair, A. Abd El-Azim et al. · 2020 · Journal of The Egyptian Society of Nephrology and Transplantation
  66. Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals
    Roger J. M. Brüggemann, Dirk Jan A. R. Moes, Koen P. van Rhee, Nils E. van ‘t Veer, Birgit C. P. Koch, Mara van Rossum, A. Vermeulen Windsant - van den Tweel, Monique H E Reijers, Roland R.J. van Kimmenade, Janette C. Rahamat-Langendoen et al. · 2021 · International Journal of Antimicrobial Agents
  67. The clinical characteristics and treatment approaches of COVID-19: a concise review
    Sajjad Eslamkhah, Nazila Alizadeh, Khalil Hajiasgharzadeh, Masoud Eslamkhah, Ahad Mokhtarzadeh, Behzad Baradaran · 2021 · Pharmaceutical Sciences
  68. Chloroquine-induced Prolonged QT Interval in COVID-19 Patients in Indonesia: Case Series
    Putu Dyah Widyaningsih, Putu Gita Pranata Putra, DG Wedha Asmara, Ketut Erna Bagiari, Agus Santosa, Harapan Harapan, Sri Masyeni · 2021 · Biomedical & Pharmacology Journal
  69. Effect of Hydroxychloroquine on QTc in Patients Diagnosed with COVID-19: A Systematic Review and Meta-Analysis
    Angelos Arfaras-Melainis, Andreas Tzoumas, Damianos G. Kokkinidis, Maria Salgado Guerrero, Dimitrios Varrias, Xiaobo Xu, Luis Ernesto Cerna, Ricardo Avendaño, Cameron Kemal, Leonidas Palaiodimos et al. · 2021 · Journal of Cardiovascular Development and Disease
  70. Immunological and Clinical Aspects of Immune Responses to SARS-CoV-2
    Ali Reza Andalib, Maedeh Radandish · 2020 · The Journal of Qazvin University of Medical Sciences
  71. Information on lifestyle habits of individuals with COVID-19 worldwide: Review of literature
    Luiz Eduardo Silva, Gibson Barros de Almeida Santana, Rodrigo da Rosa Mesquita, Tatiana Farias de Oliveira, Gabriel Monteiro Arnozo, Aisla Graciele Galdino dos Santos, Etvaldo Rodrigues da Silva Filho, Fernanda Mayara Santos Santana, Saulo Henrique Salgueiro de Aquino, Euclides José Oliveira da Cunha et al. · 2021 · Revista Portal Saúde e Sociedade
  72. Avaliação das potenciais interações dos medicamentos investigados para tratamento da Covid-19 segundo o manuseio medicamentoso precoce do ministério da saúde / Evaluation of potential interactions of medicines investigated for the treatment of Covid-19 according to the early drug handling of the ministry of health
    Júlia Victória Batista Oliveira, Graziella Picanço Silva, Lucas Pereira Paz Siqueira, Ana Camila Garcia Sena Souza, Christian Diniz Lima e Silva, Paulo Marcelo Pedroso Pereira · 2021 · Brazilian Journal of Development
  73. A Narrative Review of Existing Options for COVID-19-Specific Treatments
    Wasey Ali Yadullahi Mir, Abdul Hasan Siddiqui, Gautam Kishore Valecha, Shawn Patel, Fatima Ayub, Riddhi Upadhyay, Sana Alhajri, Suman Gaire, Dhan Bahadur Shrestha · 2021 · Advances in Virology
  74. IMPACTOS GERADOS PELO USO DE CLOROQUINA, HIDROXICLOROQUINA E AZITROMICINA COMO TRATAMENTO DE PACIENTES COM COVID-19
    Fabio José da Silva Melo, Carlos Laubert Nunes Lemos, Alexandre Torres Vasconcelos, Marcos Paulo Santos Passos · 2021 · Revista Ibero-Americana de Humanidades, Ciências e Educação
  75. Efficacy of treatments tested in COVID-19 patients with cardiovascular disease. A meta-analysis
    Soumaya Ben‐Aicha, Jacqueline Buchanan, Prakash P Punjabi, Costanza Emanueli, Marco Moscarelli · 2022 · Perfusion
  76. Reuse of drugs in the treatment of COVID-19
    Alessandra Isabô Neri, Lí­lian Carla Carneiro, Cristiene Costa Carneiro, Aroldo Vieira de Moraes Filho, Lee Chen-Chen · 2022 · Research Society and Development
  77. Evaluation of the Efficacy of Chloroquine and Hydroxychloroquine in the Treatment of Individuals with COVID-19: A Systematic Review
    Luanne Cardoso Mendes, J. Ávila, Adriano Alves Pereira · 2022 · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany
  78. Clinical and electrocardiographic outcomes evaluated by telemedicine of outpatients with clinical suspicion of COVID-19 treated with chloroquine compounds in Brazil†
    Bruno Ramos Nascimento, Gabriela Miana Paixao, Luís Antônio Batista Tonaco, Ana Carolina D. Alves, David C. Peixoto, Leonardo Bonisson Ribeiro, Mayara Santos Mendes, Paulo Rodrigues Gomes, Magda Carvalho Pires, Antônio Luiz Pinho Ribeiro · 2023 · Frontiers in Cardiovascular Medicine
  79. Hydroxychloroquine induces long QT syndrome by blocking hERG channel
    Xin Yu Zhao, Lihua Sun, Chao Chen, Jieru Xin, Yan Zhang, Yunlong Bai, Zhenwei Pan, Yong Zhang, Baoxin Li, Yanjie Lv et al. · 2023 · Frigid Zone Medicine
  80. Trends in the Management of Aged Population During the COVID-19 Pandemic
    Sushil Kumar Maheshwari · 2023 · Springer eBooks
  81. Comment on “Is the type of diabetes treatment relevant to outcome of COVID ‐19?”
    Rimesh Pal, Mainak Banerjee · 2020 · Journal of Diabetes
  82. The status surrounding chloroquine and other drugs as potential anti-infective agents for COVID-19
    Dindial Ramotar · 2020 · Expert Review of Respiratory Medicine
  83. Response to: ‘The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients’ by Favalli et al
    Vasco C. Romão, Ana Rita Cruz-Machado, João Eurico Fonseca · 2020 · Annals of the Rheumatic Diseases
  84. COVID-19 and hydroxychloroquine: Let the available data speak for themselves
    Ugo Paliani, Andrea Cardona · 2020 · European Journal of Internal Medicine
  85. Comment on Ye et al ‘Presence of respiratory failure of COVID-19 infection in rheumatism patients in Wuhan, China‘
    Xiaohuan Chen, Chih‐Jung Yeh, Hanyou Mo, James Cheng Chung Wei · 2020 · Annals of the Rheumatic Diseases
  86. Characteristics of 24,516 Patients Diagnosed with COVID-19 Illness in a National Clinical Research Network: Results from PCORnet ®
    Jason P. Block, Keith A. Marsolo, Kshema Nagavedu, L. Charles Bailey, Henry Cruz, Christopher B. Forrest, Kevin Haynes, Adrian F. Hernandez, Rainu Kaushal, Abel Kho et al. · 2020 · medRxiv
  87. Repurposing Colchicine for the Management of COVID-19: A Systematic Review and Meta-analysis
    Rashmi Ranjan Mohanty, Bikash Ranjan Meher, Biswa Mohan Padhy, Smita Das · 2021 · medRxiv
  88. Hydroxychloroquine for Treatment of COVID‐19 Patients: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Vinícius Ynoe de Moraes, Alexandre Rodrigues Marra, Leandro Luongo Matos, Ary Serpa Neto, Luiz Vicente Rizzo, Miguel Cendoroglo Neto, Mário Lenza · 2021 · Research Square
  89. Can We Really Trust the Findings of the COVID-19 Research? Quality Assessment of Randomized Controlled Trials Published on COVID-19
    Athira S Joshy, Christy Thomas, Saphal Surendran, Krishna Undela · 2022 · medRxiv
  90. Current evidence on chloroquine and hydroxychloroquine and their role in the treatment and prevention of COVID-19
    Rephaim Mpofu, Clifford George Banda, Hannah May Gunter, Enkosi Mondleki, Gayle Tatz, Phumla Sinxadi, Karen Cohen, Karen Irma Barnes, Marc Blockman · 2020
  91. A structure-based drug repurposing approach by considering the twenty four SARS-CoV2 Targets: A consensus scoring approach
    Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, Kikrusenuo Kiewhuo, Selvaraman Nagamani, Garikapati Narahari Sastry · 2022 · Research Square
  92. Energy dynamics for systemic configurations of virus-host co-evolution
    Alessandra Romano, Marco Casazza, Francesco Gonella · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Therapien gegen COVID-19 — ein Update
    Thomas M. Müller · 2020 · MMW - Fortschritte der Medizin
  94. BET 2: Hydroxychloroquine in the treatment of COVID-19
    Laura M. Howard, Janos Peter Baombe, Charles Reynard · 2020 · Emergency Medicine Journal
  95. Chloroquine for treatment of COVID-19 - a pig in a poke?
    Roger J. M. Brüggemann, Dirk Jan A. R. Moes, Koen P. van Rhee, Nils E. van ‘t Veer, Birgit C. P. Koch, Mara van Rossum, A. Vermeulen Windsant - van den Tweel, Monique H E Reijers, Roland R.J. van Kimmenade, Janette C. Rahamat-Langendoen et al. · 2020 · medRxiv
  96. Mortality Due to COVID-19 in the Elderly: Integrative Literature Review
    Dayara de Nazaré Rosa de Carvalho, Viviane Ferraz Ferreira de Aguiar, Dandara de Fátima Ribeiro Bendelaque, Lorena Nayara Alves Neves, Celice Ruanda Oliveira Sobrinho, Jaqueline Dantas Neres Martins, Rafael Everton Assunção Ribeiro da Costa, Susi dos Santos Barreto de Souza, Mônica Custódia do Couto Abreu Pamplona, Márcia Helena Machado Nascimento et al. · 2020 · International Journal of TROPICAL DISEASE & Health
  97. nCOVID-19: Its diagnosis, possible preventive measures, therapeutic interventions and management
    Mrinal Kanti Poddar, Apala Chakraborty · 2020 · Archives of Community Medicine and Public Health
  98. New insights on potential therapeutic options and vaccines for corona virus disease-2019
    Samson Baranzan Wayah, Richard Auta, Peter Maitalata Waziri, Emmanuel Haruna · 2020 · Reviews in Medical Microbiology
  99. COVID-19 und die Bedeutung der kardiovaskulären Komorbidität
    Hatim Seoudy, Norbert Frey · 2020 · DMW - Deutsche Medizinische Wochenschrift
  100. Comprehensive Systematic Review to Identify putative COVID-19 Treatments: Roles for Immunomodulator and Antiviral Treatments
    Thomas M. Hill, Mark R Baker, Lawrence Isherwood, Lennard Y. W. Lee · 2020 · medRxiv